Margaretta S Page - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Margaretta S Page

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Neuro-Oncology Practice|August 7, 2019

Creating a caregiver program in neuro-oncologyMargaretta S Page, Susan M Chang

Clinical Journal of Oncology Nursing|December 30, 2006

Putting evidence into practice: evidence-based interventions for sleep-wake disturbancesMargaretta S Page, Ann M Berger, Lauran B Johnson

Neuro-Oncology|January 31, 2006

Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant gliomaMichael D Prados, Kathleen R Lamborn, Susan Chang, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Neuro-Oncology Practice|August 7, 2019

Creating a caregiver program in neuro-oncologyMargaretta S Page, Susan M Chang

Clinical Journal of Oncology Nursing|December 30, 2006

Putting evidence into practice: evidence-based interventions for sleep-wake disturbancesMargaretta S Page, Ann M Berger, Lauran B Johnson

Neuro-Oncology|January 31, 2006

Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant gliomaMichael D Prados, Kathleen R Lamborn, Susan Chang, et al.

Pageof 1